Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics ...

Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics, Inc. ...

The company is strategically targeting markets where patents expire earliest, with India's launch timeline slightly later than Canada and Brazil, he indicated at the Nasscom GCC Summit here.

Americans medicine cabinets are filled with prescription drugs that are often made in or contain ingredients from China or India. Pharmaceutical experts warn patients will likely eventually see ...

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease. The approval ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro ...

Stocktwits - Sunshine Biopharma, Inc.’s stock rose over 3% on Monday, lifting retail investor sentiment, after the company said its Canadian subsidiary had launched a generic version of an oncology ...

Glenmark is set to launch a generic version of Teva’s Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to begin in May 2025. The company will launch ...

Hikma has acquired the FDA-approved Abbreviated New Drug Application for trametinib ... When launched, Hikma will have 180 days of U.S. generic market sales exclusivity for this product, which ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing (OSD) is no exception. Often when transitioning molecules from phase I to II, ...